These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 1379027)

  • 1. T cells from normal and myasthenic individuals recognize the human acetylcholine receptor: heterogeneity of antigenic sites on the alpha-subunit.
    Melms A; Malcherek G; Gern U; Wiethölter H; Müller CA; Schoepfer R; Lindstrom J
    Ann Neurol; 1992 Mar; 31(3):311-8. PubMed ID: 1379027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of CD4+ T cells from myasthenic patients and healthy subjects of biosynthetic and synthetic sequences of the nicotinic acetylcholine receptor.
    Diethelm-Okita B; Wells GB; Kuryatov A; Okita D; Howard J; Lindstrom JM; Conti-Fine BM
    J Autoimmun; 1998 Apr; 11(2):191-203. PubMed ID: 9650099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis.
    Yoshikawa H; Lambert EH; Walser-Kuntz DR; Yasukawa Y; McCormick DJ; Lennon VA
    J Immunol; 1997 Aug; 159(3):1570-7. PubMed ID: 9233656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune T lymphocytes in myasthenia gravis. Determination of target epitopes using T lines and recombinant products of the mouse nicotinic acetylcholine receptor gene.
    Melms A; Chrestel S; Schalke BC; Wekerle H; Mauron A; Ballivet M; Barkas T
    J Clin Invest; 1989 Mar; 83(3):785-90. PubMed ID: 2466050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylcholine receptor-specific T-lymphocyte clones in the normal human immune repertoire: target epitopes, HLA restriction, and membrane phenotypes.
    Salvetti M; Jung S; Chang SF; Will H; Schalke BC; Wekerle H
    Ann Neurol; 1991 May; 29(5):508-16. PubMed ID: 1713438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor.
    Matsuo H; Batocchi AP; Hawke S; Nicolle M; Jacobson L; Vincent A; Newsom-Davis J; Willcox N
    J Immunol; 1995 Oct; 155(7):3683-92. PubMed ID: 7561069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell activation in vitro by helper T cells specific to region alpha 146-162 of Torpedo californica nicotinic acetylcholine receptor.
    Rosenberg JS; Oshima M; Atassi MZ
    J Immunol; 1996 Oct; 157(7):3192-9. PubMed ID: 8816433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides.
    Fujii Y; Lindstrom J
    J Immunol; 1988 Mar; 140(6):1830-7. PubMed ID: 2450133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes.
    Nicolle MW; Nag B; Sharma SD; Willcox N; Vincent A; Ferguson DJ; Newsom-Davis J
    J Clin Invest; 1994 Apr; 93(4):1361-9. PubMed ID: 7512979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myasthenia gravis. Residues of the alpha and gamma subunits of muscle acetylcholine receptor involved in formation of immunodominant CD4+ epitopes.
    Moiola L; Protti MP; McCormick D; Howard JF; Conti-Tronconi BM
    J Immunol; 1994 May; 152(9):4686-98. PubMed ID: 7908921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The autoimmune response of different mouse strains to T-cell epitopes of the human acetylcholine receptor alpha subunit.
    Brocke S; Dayan M; Rothbard J; Fuchs S; Mozes E
    Immunology; 1990 Apr; 69(4):495-500. PubMed ID: 1692300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological heterogeneity of autoreactive T lymphocytes against the nicotinic acetylcholine receptor in myasthenic patients.
    Zhang Y; Schluep M; Frutiger S; Hughes GJ; Jeannet M; Steck A; Barkas T
    Eur J Immunol; 1990 Dec; 20(12):2577-83. PubMed ID: 2269325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell epitopes in experimental autoimmune myasthenia gravis of the rat: strain-specific epitopes and cross-reaction between two distinct segments of the alpha chain of the nicotinic acetylcholine receptor (Torpedo californica).
    Zhang Y; Barkas T; Juillerat M; Schwendimann B; Wekerle H
    Eur J Immunol; 1988 Apr; 18(4):551-7. PubMed ID: 2452743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor.
    Bellone M; Ostlie N; Lei SJ; Wu XD; Conti-Tronconi BM
    J Immunol; 1991 Sep; 147(5):1484-91. PubMed ID: 1715360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC class II presentation of human acetylcholine receptor in Myasthenia gravis: binding of synthetic gamma subunit sequences to DR molecules.
    Yuen MH; Macklin KD; Conti-Fine BM
    J Autoimmun; 1996 Feb; 9(1):67-77. PubMed ID: 8845056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis.
    Hohlfeld R; Conti-Tronconi B; Kalies I; Bertrams J; Toyka KV
    J Immunol; 1985 Oct; 135(4):2393-9. PubMed ID: 2411794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune T cell recognition of human acetylcholine receptor: the sites of T cell recognition in myasthenia gravis on the extracellular part of the alpha subunit.
    Oshima M; Ashizawa T; Pollack MS; Atassi MZ
    Eur J Immunol; 1990 Dec; 20(12):2563-9. PubMed ID: 2269324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoregulatory CD8+ cells recognize antigen-activated CD4+ cells in myasthenia gravis patients and in healthy controls.
    Yuen MH; Protti MP; Diethelm-Okita B; Moiola L; Howard JF; Conti-Fine BM
    J Immunol; 1995 Feb; 154(3):1508-20. PubMed ID: 7529806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ T cell response to the human acetylcholine receptor alpha subunit in myasthenia gravis. A study with synthetic peptides.
    Protti MP; Manfredi AA; Straub C; Howard JF; Conti-Tronconi BM
    J Immunol; 1990 Feb; 144(4):1276-81. PubMed ID: 1968078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.